education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Hong Kong
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Hong Kong
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
points
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
×
Distributed by
Firma Chun Cheong
Zuellig
Marketed by
Novartis
Apply
Distributed by
Firma Chun Cheong
Zuellig
Marketed by
Novartis
Apply
ALCON-COUVREUR NV
Filter
Featured products of
Alcon-Couvreur
Show All
Show All
Beovu
Beovu
Beovu soln for inj in pre-filled syringe 6 mg/0.05 mL
brolucizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Distributed by
Firma Chun Cheong
Show All
Show All
Beovu
Beovu
Beovu soln for inj in pre-filled syringe 6 mg/0.05 mL
brolucizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Distributed by
Zuellig
Show All
Show All
Beovu
Beovu
Beovu soln for inj in pre-filled syringe 6 mg/0.05 mL
brolucizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Marketed by
Novartis
Show All
Show All
Beovu
Beovu
Beovu soln for inj in pre-filled syringe 6 mg/0.05 mL
brolucizumab
Packing/Price
1's
MIMS Class
Other Eye Preparations
ATC Classification
S01LA06 - brolucizumab : Belongs to the class antineovasculatisation agents. Used in the management of neovascular macular degeneration.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign Up
Already a member?
Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Continue with Google
OR
Sign Up
Already a member?
Sign in